Student Loan Sudden...
Health Care: Drugs
Insmed Inc. (INSM: NASDAQ)
$12.23 -0.53 | -4.15%
06/19/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 12.76 |
| 52 Week High | 14.30 |
| 52 Week Low | 2.86 |
| Avg. Daily Vol. (Mil) | 0.36 |
| Beta (3 year) | 0.41 |
| Share Related Items | |
| Mkt Cap (Mil) | 405.71 |
| Shares Out (Mil) | 31.80 |
| Float (Mil) | 24.30 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.00 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.14 |
| Total Debt / Equity | 0.19 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 3.77 |
| Price/Cash Flow | -8.60 |
| Per Share Data | |
| Earnings | -1.72 |
| Sales | 0.00 |
| Book Value | 3.38 |
| Cash Flow | -1.49 |
| Business Summary | |
|---|---|
| Insmed, Inc. is a development-stage biopharmaceutical company. The Company develops inhaled treatments for serious lung infections. | |
| General Information | |
| 9 Deer Park Drive
Suite C Monmouth Junction, NJ 08852 |
|
| www.insmed.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 41 | |
| CEO: Mr. William H. Lewis | |
| Short Interest | |
| Current Month (Mil) | 1.95 |
| Previous Month (Mil) | 1.49 |
| Short Interest Ratio (Days) | 3.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -33.70 |
| Return on Investments | -39.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with INSM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- Userbetterlatethannever
- UserStock Choices
- Userjstanley Portfolio 1
- Userlgselsorlaw Portfolio 1
- Userkazooskibum
- Usersmercado
- UserMr. T fund
- UserLorirain II
Latest INSM Headlines from TheStreet
- Programmed Insider Buying? Yes, at Insmed and United Therapeutics 01.24.13 | 08:01 am
- 4 Plays Under $10 on the Rise 11.13.12 | 05:11 pm
- Insmed's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 01:08 pm
- 5 Under-$10 Stocks Poised for a Breakout 06.07.12 | 02:06 pm
- Insmed Stock Gaps Down On Today's Open (INSM) 10.10.11 | 09:10 am
- Insmed Inc. Stock Downgraded (INSM) 08.22.11 | 08:08 am
- Insmed Stock Soars (INSM) 08.11.11 | 03:08 pm
- 'Strong Rally' in Small-Caps May Emerge 08.09.11 | 10:08 am
- Insmed Stock Gaps Down On Today's Open (INSM) 08.02.11 | 09:08 am
- Insmed Inc. Stock Upgraded (INSM) 07.22.11 | 07:07 am
Press Releases for INSM
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Insmed Incorporated In Connection With Executive Compensation - PR Newswire 01.17.13 | 02:01 pm
- Insmed To Present At 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 12.13.12 | 08:12 am
- Insmed Announces CLEAR-108 Phase 3 Clinical Study Of ARIKACE® In Cystic Fibrosis Patients With Pseudomonas Lung Infections Has Completed Target Enrollment - PR Newswire 11.13.12 | 08:11 am
- Insmed To Present At Two Upcoming Investor Conferences - PR Newswire 11.12.12 | 08:11 am
- Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler As Chief Financial Officer - PR Newswire 11.07.12 | 07:11 am
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Insmed To Present At Stifel Nicolaus 2012 Healthcare Conference - PR Newswire 08.30.12 | 08:08 am
- Insmed To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference - PR Newswire 08.14.12 | 08:08 am
- Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors - PR Newswire 08.06.12 | 08:08 am
- Insmed Receives Second Composition Of Matter Patent For ARIKACE® - PR Newswire 08.02.12 | 08:08 am
Partner Headlines for INSM
- Benzinga's Microcap Movers for Friday January 20, 2012 - Benzinga 01.22.12 | 10:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BMS Drug Deemed Too Costly: Weekly Round-Up Of Biotech Failures And Mishaps - Seeking Alpha 10.16.11 | 08:10 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Thursday's Top Performing Small Cap Stocks (AONE, AIQ, KV.A, INSM, CXPO) - NASDAQ 08.12.11 | 03:08 pm
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Portfolio Moves in a Volatile Market - Seeking Alpha 05.09.10 | 05:05 am
